NEM vs ZBH · P/E 14, rev $13.43B vs P/E 23, rev $4.26B
Newmont Goldcorp Corp (NEM) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Newmont Goldcorp Corp (NEM) is a gold company listed on NYSE.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Latest reported NEM revenue for 2026-06-30 was $13.43B. Net income was $5.46B. Revenue was up 83.7% from 2026-03-31 to 2026-06-30. NEM currently screens at market cap $112.81B and trailing P/E 13.7.
Latest reported ZBH revenue for 2026-06-30 was $4.26B. Net income was $436.5M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
NEM currently screens at market cap $112.81B and trailing P/E 13.7. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the NEM and ZBH stock pages for the full models.
Not investment advice.